A victory for genes.

Nat Med · 2013

editorial · Level V

Where this comes from

Abstract

The ability to patent human genes has been costly to researchers and patients, and has restricted competition in the biotech marketplace. The recent US Supreme Court decision making isolated human genes unpatentable will bring freedom of choice to the patient, and level the playing field for research and development.

Medical subject headings